Fecal microbiota treatment for kids with active ulcerative colitis
Part of Digestive system clinical trials.
This trial tests whether taking capsules made from stool donors’ “good gut bacteria” can improve moderate, active ulcerative colitis in children. You might join if your child has symptoms despite stable usual treatments, and can safely take the study capsules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is age 8 to 17
- Your child has ulcerative colitis for more than 3 months (not only a very small rectum-only area)
- Symptoms are moderate and active, and improve with steroids right before starting the study
- Usual ulcerative colitis medicines have been stable for over 3 months
- Your child can swallow the study capsules
- No recent antibiotics/antifungals, and no recent C. difficile infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether transferring healthy stool bacteria into the gut (fecal microbiota transplantation, or FMT) can improve symptoms in children with ulcerative colitis. It may help by changing gut bacteria, especially for children who are newly diagnosed or who didn’t respond to standard treatments.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
This trial tests whether transplanting stool bacteria (called fecal microbiota transplantation, or FMT) can improve symptoms in people with active ulcerative colitis. You may be able to help test a new approach for restoring gut bacteria, while receiving standard ulcerative colitis care from your doctor.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This trial screens people as potential donors for a fecal microbiota transplant program used for ulcerative colitis. It checks safety and eligibility so the transplant process is as safe as possible for people with active disease.
This trial tests whether fecal microbiota transfer (a stool-based therapy) can improve outcomes when added to starting a new biologic medicine for ulcerative colitis. It compares fecal transplant versus placebo (a sham treatment) to see if symptoms and inflammation improve faster or more strongly.
Hear when a new Pediatric Ulcerative Colitis in Remission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.